Roche Molecular Systems Director of Engineering Salaries in Coeur D Alene, ID
The average Roche Molecular Systems Director of Engineering in Coeur D Alene, ID earns an estimated $220,633 annually, which includes an estimated base salary of $178,710 with a $41,923 bonus. Roche Molecular Systems' Director of Engineering compensation is $33,252 more than the US average for a Director of Engineering. Director of Engineering salaries at Roche Molecular Systems in Coeur D Alene, ID can range from $94,000 - $473,000.
In Coeur D Alene, ID, The Engineering Department at Roche Molecular Systems earns $9,310 more on average than the Design Department.
Last updated 2 years ago.
- $178,710
- avg. base
- $41,923
- avg. bonus
Director of Engineering Salaries at Roche Molecular Systems
In Coeur D Alene, ID, Directors of Engineering earn $5,352 more than Directors of Engineering.
Compensation at Roche Molecular Systems by Department
In Coeur D Alene, ID, The Engineering Department averages $9,310 more than the Design Department, and $5,243 less than the Business Development Department
Director of Engineering Compensation by Gender (All Companies)
The average female Director of Engineering at companies similar size to Roche Molecular Systems reported making $233,006, while the average male Director of Engineering at similar sized companies reported making $235,035.
Director of Engineering Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Director of Engineering at companies similar size to Roche Molecular Systems reported making $247,783, while the average Native American Director of Engineering at similar sized companies reported making $150,000.
How Directors of Engineering at Roche Molecular Systems Rate Their Compensation
The majority of Directors of Engineering at Roche Molecular Systems believe they're compensated fairly. 100% of Directors of Engineering at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems
